BIO-B
Bio-Rad Laboratories, Inc.
NYSE · Healthcare · Medical - Devices · US
$381.37
+4.46%Aug 13, 2026, 07:34 UTC
First Trust Advisors LP reduced its stake in Bio-Rad Laboratories, Inc. by 97.3% during the quarter, selling 55,710 shares and retaining 1,522 shares, according to a recent SEC filing.
Source:Aug 4, 2026, 20:15 UTC
Bio-Rad Laboratories reported its financial results for the second quarter ended June 30, 2026, with reported revenue flat year-over-year, as growth in Clinical Diagnostics was offset by softness in Life Science.